The Journal of Antibiotics
 | |
| Discipline | Microbiology |
|---|---|
| Language | English |
| Edited by | Kuniaki Tatsuta |
| Publication details | |
| History | 1948–present |
| Publisher | |
| Frequency | Monthly |
| 3.3 (2022) | |
| Standard abbreviations | |
| ISO 4 | J. Antibiot. |
| NLM | J Antibiot (Tokyo) |
| Indexing | |
| CODEN | JANTAJ |
| ISSN | 0021-8820 (print) 1881-1469 (web) |
| OCLC no. | 01642415 |
| Links | |
The Journal of Antibiotics is a peer-reviewed medical journal published by the Nature Publishing Group for the Japan Antibiotics Research Association.
The journal seeks to endorse studies on antibiotics and associated types of biologically-active substances.
In June 2020, the journal published a pioneer systematic review on ivermectin and COVID-19 by Fatemeh Heiday and Reza Gharebaghi which has become highly cited.[1]
Abstracting and indexing
The journal is abstracted and indexed for example in:
- CAB Abstracts[2]
- Current Contents/Clinical Medicine[3]
- MEDLINE[4]
- Science Citation Index[3]
- Scopus[5]
According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.3.[6]
References
- ^ Heidary, Fatemeh; Gharebaghi, Reza (2020). "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen". The Journal of Antibiotics. 73 (9): 593–602. doi:10.1038/s41429-020-0336-z. ISSN 0021-8820. PMC 7290143. PMID 32533071.
- ^ "Serials cited". CAB Abstracts. CABI. Retrieved 2014-12-27.
- ^ a b "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2024-02-12.
- ^ "The Journal of Antibiotics". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-27.
- ^ "Source details: The Journal of Antibiotics". Scopus Preview. Nature Publishing Group. Retrieved 2024-02-12.
- ^ "Journals Ranked by Impact: The Journal of Antibiotics". 2022 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2023.
External links